Tarsus Pharmaceuticals, Inc. TARS Tenant improvement allowance
Tenant improvement allowance at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:LesseeTenantImprovementAllowance.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s tenant improvement allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s tenant improvement allowance?
- Tarsus Pharmaceuticals, Inc. (TARS) reported tenant improvement allowance of $5.8M in Q4 2024.
- What does tenant improvement allowance mean?
- This represents the funding provided by a landlord to a tenant to cover the costs of customizing or renovating leased space. It is a vital component of capital expenditure management, as it reduces the net cash outlay required for facility setup.